Human genetics · 2022
Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Velde Hedwig M, Reurink Janine, Held Sebastian, Li Catherina H Z, Yzer Suzanne, Oostrik Jaap, Weeda Jack, Haer-Wigman Lonneke, Yntema Helger G, Roosing Susanne, Pauleikhoff Laurenz, Lange Clemens, Whelan Laura, Dockery Adrian, Zhu Julia, Keegan David J, Farrar G Jane, Kremer Hannie, Lanting Cornelis P, Damme Markus, Pennings Ronald J E
Аннотация
Usher syndrome (USH) is an autosomal recessively inherited disease characterized by sensorineural hearing loss (SNHL) and retinitis pigmentosa (RP) with or without vestibular dysfunction. It is highly heterogeneous both clinically and genetically. Recently, variants in the arylsulfatase G (ARSG) gene have been reported to underlie USH type IV. This distinct type of USH is characterized by late-onset RP with predominantly pericentral and macular changes, and late onset SNHL without vestibular dysfunction. In this study, we describe the USH type IV phenotype in three unrelated subjects. We identified three novel pathogenic variants, two novel likely pathogenic variants, and one previously described pathogenic variant in ARSG. Functional experiments indicated a loss of sulfatase activity of the mutant proteins. Our findings confirm that ARSG variants cause the newly defined USH type IV and support the proposed extension of the phenotypic USH classification.